SCHEMBL4440294

SCHEMBL4440294

NCCNC(=O)[C@@H](CS)Cc1cccc(Cl)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MME P08473 4/20 0.53
ACE P12821 3/20 0.53
ALDH1A1 P00352 2/20 0.49
HPGD P15428 1/20 0.49
MAPK1 P28482 1/20 0.49
HSD17B10 Q99714 1/20 0.49
MEN1 O00255 1/20 0.49
MAPT P10636 1/20 0.49
ECE1 P42892 1/20 0.49
BLM P54132 1/20 0.49
NPEPPS P55786 1/20 0.49
KMT2A Q03164 1/20 0.49
NPC1 O15118 1/20 0.43
HTT P42858 1/20 0.43
RAB9A P51151 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
PNMT P11086 1/20 0.43
CTSV O60911 3/20 0.43
CTSL P07711 3/20 0.43
CTSS P25774 3/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4440292 0.85 MME (0.56) MMEACEALDH1A1HPGDMAPK1
SCHEMBL4442572 0.84 MME (0.74) MMEACEALDH1A1HPGDMAPK1
SCHEMBL3623644 0.77 MME (0.68) MMEACEALDH1A1HPGDMAPK1
SCHEMBL13821843 0.73 CTSL (0.49) ALDH1A1NPC1HTTRAB9ASMN1; SMN2
SCHEMBL9724958 0.73 MAPT (0.62) MMEACEALDH1A1HPGDMAPK1
SCHEMBL2967426 0.72 MME (0.50) MMEACEALDH1A1HPGDMAPK1
SCHEMBL1817242 0.72 PNMT (0.53) PNMTFOLH1
SCHEMBL1817614 0.72 PNMT (0.53) PNMTFOLH1
SCHEMBL7281509 0.71 MME (0.71) MMEACEALDH1A1HPGDMAPK1
Hydrochloric Acid SCHEMBL4619275 0.71 PNMT (0.51) PNMTFOLH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2132187-A2 DUAL-ACTING ANTIHYPERTENSIVE AGENTS Theravance, Inc. (US) 2009-12-16 EP disclosed
WO-2008097459-A2 DUAL-ACTING ANTIHYPERTENSIVE AGENTS THERAVANCE, INC. (US) 2008-08-14 WO disclosed